Last updated on July 2008

Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Mycoses | Neutropenia | Bone Marrow Transplantation
  • Age: Between 15 - 65 Years
  • Gender: Male or Female
  • Other:
    Immunocompromised adults who are treated with voriconazole due to proven or probable
    invasive fungal infections

You may not be eligible for this study if the following are true:

  • Patients who have been treated with other investigational drugs
    Patients with liver dysfunction (aminotransferase level ≥ 5 times the upper limit of
    normal, bilirubin or alkaline phosphatase level > 3 times the upper limit of normal)
    Patients with renal dysfunction (Cr level > 2.5 times the upper limit of normal)
    Pregnant women
    Patients younger than 15 years of age

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.